3 completed, 1 unknown. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Unknown 1 |
Follow IgG Deficiency: new trials by email Literature Review of IgG Deficiency trials Research Report on IgG Deficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IVIG Treatment for Asthmatic Patients With IgG Subclass Deficiency Immune Globulin - Asthma | Phase 3 | Unknown | Ajou University School of Medicine | 30 | 2013-12-01 | 2016-05-02 |
| Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) Immunoglobulins Intravenous (Human) - Agammaglobulinemia, IgG Deficiency | Phase 3 | Completed | CSL Behring | 55 | 2005-11-01 | 2012-10-26 |
| Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) Immunoglobulins Intravenous (Human) - Agammaglobulinemia, IgG Deficiency | Phase 3 | Completed | CSL Behring | 89 | 2004-09-01 | 2012-06-06 |
| Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID) Immunoglobulins Intravenous (Human) - Agammaglobulinemia, IgG Deficiency | Phase 3 | Completed | CSL Behring | 42 | 2004-09-01 | 2011-02-11 |
Agammaglobulinemia (3) · Common Variable Immunodeficiency (3) · Asthma (1)
Blood Protein Disorders (4) · Dysgammaglobulinemia (4) · Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Immune System Diseases (4) · Immunologic Deficiency Syndromes (4) · Lymphatic Diseases (3) · Lymphoproliferative Disorders (3) · Bronchial Diseases (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Respiratory Hypersensitivity (1) · Respiratory Tract Diseases (1)
Immunoglobulins, Intravenous (3) · Immunoglobulins (1)
CSL Behring (3) · Ajou University School of Medicine (1)
United States (1)